应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVXL Anavex Life Sciences Corp.
已收盘 04-16 16:00:00 EDT
8.84
-0.28
-3.07%
盘后
8.84
+0.00
0.00%
18:00 EDT
最高
9.09
最低
8.61
成交量
60.23万
今开
9.02
昨收
9.12
日振幅
5.27%
总市值
7.52亿
流通市值
7.27亿
总股本
8,506万
成交额
530.07万
换手率
0.73%
流通股本
8,226万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.04%报8.66美元
市场透视 · 04-16 18:52
Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.04%报8.66美元
Anavex Life Sciences Corp.盘中异动 快速上涨5.15%
市场透视 · 04-11
Anavex Life Sciences Corp.盘中异动 快速上涨5.15%
Anavex Life Sciences Corp.盘中异动 临近午盘股价大涨5.07%
市场透视 · 03-10
Anavex Life Sciences Corp.盘中异动 临近午盘股价大涨5.07%
Anavex Life Sciences Corp.盘中异动 急速拉升5.12%
市场透视 · 03-03
Anavex Life Sciences Corp.盘中异动 急速拉升5.12%
Anavex Life Sciences Corp.盘中异动 股价大涨5.05%
市场透视 · 02-18
Anavex Life Sciences Corp.盘中异动 股价大涨5.05%
Anavex Life Sciences Corp.盘中异动 股价大涨5.37%报8.93美元
市场透视 · 02-14
Anavex Life Sciences Corp.盘中异动 股价大涨5.37%报8.93美元
Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年
财报速递 · 02-12
Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年
Anavex Life Sciences(AVXL.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.14美元,前值为-0.11美元,预期值为-0.17美元。
金融界 · 02-12
Anavex Life Sciences(AVXL.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.14美元,前值为-0.11美元,预期值为-0.17美元。
Anavex Life Sciences Corp.盘中异动 股价大跌5.03%报8.37美元
市场透视 · 02-11
Anavex Life Sciences Corp.盘中异动 股价大跌5.03%报8.37美元
Anavex Life Sciences Corp.盘中异动 早盘急速上涨5.09%
市场透视 · 02-04
Anavex Life Sciences Corp.盘中异动 早盘急速上涨5.09%
Anavex Life Sciences Corp.盘中异动 急速下挫5.18%
市场透视 · 02-03
Anavex Life Sciences Corp.盘中异动 急速下挫5.18%
Anavex Life Sciences Corp.盘中异动 股价大跌5.12%
市场透视 · 01-31
Anavex Life Sciences Corp.盘中异动 股价大跌5.12%
Anavex Life Sciences Corp.盘中异动 早盘快速跳水5.19%报9.95美元
市场透视 · 01-27
Anavex Life Sciences Corp.盘中异动 早盘快速跳水5.19%报9.95美元
Anavex Life Sciences Corp.盘中异动 股价大涨5.06%
市场透视 · 01-24
Anavex Life Sciences Corp.盘中异动 股价大涨5.06%
Anavex Life Sciences Corp.盘中异动 下午盘股价大涨5.10%
市场透视 · 01-21
Anavex Life Sciences Corp.盘中异动 下午盘股价大涨5.10%
Anavex Life Sciences Corp.盘中异动 急速跳水5.12%报9.63美元
市场透视 · 01-17
Anavex Life Sciences Corp.盘中异动 急速跳水5.12%报9.63美元
Anavex Life Sciences Corp.盘中异动 股价大跌5.10%报10.75美元
市场透视 · 01-16
Anavex Life Sciences Corp.盘中异动 股价大跌5.10%报10.75美元
Anavex Life Sciences Corp.盘中异动 早盘急速上涨5.25%
市场透视 · 01-15
Anavex Life Sciences Corp.盘中异动 早盘急速上涨5.25%
Anavex Life Sciences Corp.盘中异动 股价大跌5.08%报10.66美元
市场透视 · 01-13
Anavex Life Sciences Corp.盘中异动 股价大跌5.08%报10.66美元
Anavex Life Sciences Corp.盘中异动 早盘大幅下挫5.07%
市场透视 · 01-10
Anavex Life Sciences Corp.盘中异动 早盘大幅下挫5.07%
加载更多
公司概况
公司名称:
Anavex Life Sciences Corp.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Anavex Life Sciences Corp.成立于2004年1月23日,位于内华达州。是一家临床阶段的生物制药公司,致力于开发差异化疗法,将精准医学应用于高度未满足需求的中枢神经系统(CNS)疾病。该公司目前有两个核心计划和两个种子计划。该公司的核心计划处于神经退行性疾病和神经发育疾病的临床和临床前开发的各个阶段。
发行价格:
--
{"stockData":{"symbol":"AVXL","market":"US","secType":"STK","nameCN":"Anavex Life Sciences Corp.","latestPrice":8.84,"timestamp":1744833600000,"preClose":9.12,"halted":0,"volume":602285,"hourTrading":{"tag":"盘后","latestPrice":8.84,"preClose":8.84,"latestTime":"18:00 EDT","volume":2147,"amount":18980.69,"timestamp":1744840841459},"delay":0,"floatShares":82257063,"shares":85064199,"eps":-0.552477,"marketStatus":"已收盘","change":-0.28,"latestTime":"04-16 16:00:00 EDT","open":9.02,"high":9.0903,"low":8.61,"amount":5300680.773035,"amplitude":0.052664,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.552477,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744876800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":9.12,"preHourTrading":{"tag":"盘前","latestPrice":9.15,"preClose":9.12,"latestTime":"09:11 EDT","volume":695,"amount":6161.2504075,"timestamp":1744809077739},"postHourTrading":{"tag":"盘后","latestPrice":8.84,"preClose":8.84,"latestTime":"18:00 EDT","volume":2147,"amount":18980.69,"timestamp":1744840841459},"volumeRatio":0.514433,"impliedVol":0.8707,"impliedVolPercentile":0.5299},"requestUrl":"/m/hq/s/AVXL","defaultTab":"news","newsList":[{"id":"2528715832","title":"Anavex Life Sciences Corp.盘中异动 下午盘股价大跌5.04%报8.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528715832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528715832?lang=zh_cn&edition=full","pubTime":"2025-04-17 02:52","pubTimestamp":1744829556,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日02时52分,Anavex Life Sciences Corp.股票出现异动,股价急速跳水5.04%。截至发稿,该股报8.66美元/股,成交量30.961万股,换手率0.36%,振幅4.50%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为1.62%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417025237a45b740a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417025237a45b740a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2526485126","title":"Anavex Life Sciences Corp.盘中异动 快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526485126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2526485126?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:24","pubTimestamp":1744399447,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时24分,Anavex Life Sciences Corp.股票出现异动,股价大幅拉升5.15%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为2.15%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120324089735a20d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120324089735a20d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2518743902","title":"Anavex Life Sciences Corp.盘中异动 临近午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518743902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518743902?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:37","pubTimestamp":1741621049,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时37分,Anavex Life Sciences Corp.股票出现异动,股价急速上涨5.07%。截至发稿,该股报9.11美元/股,成交量29.0493万股,换手率0.34%,振幅7.84%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.59%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310233730a26a53ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310233730a26a53ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2516860630","title":"Anavex Life Sciences Corp.盘中异动 急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516860630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516860630?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:15","pubTimestamp":1741014921,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时15分,Anavex Life Sciences Corp.股票出现波动,股价急速拉升5.12%。截至发稿,该股报8.32美元/股,成交量17.146万股,换手率0.20%,振幅4.68%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.09%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231521abe6419d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231521abe6419d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2512169464","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512169464?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:14","pubTimestamp":1739891677,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时14分,Anavex Life Sciences Corp.股票出现异动,股价急速上涨5.05%。截至发稿,该股报8.95美元/股,成交量14.6079万股,换手率0.17%,振幅4.58%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.84%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231437a24ab690&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231437a24ab690&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2511748699","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.37%报8.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511748699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511748699?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544527,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分,Anavex Life Sciences Corp.股票出现异动,股价快速拉升5.37%。截至发稿,该股报8.93美元/股,成交量6.3362万股,换手率0.07%,振幅5.19%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.30%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224847abcf0a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224847abcf0a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1169314471","title":"Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年","url":"https://stock-news.laohu8.com/highlight/detail?id=1169314471","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169314471?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:56","pubTimestamp":1739364973,"startTime":"0","endTime":"0","summary":"Anavex生命科学公司报告季度亏损为每股$,好于分析师预期的每股$,超出26.32%。这一结果较去年同期每股亏损$下降了27.27%。以上内容来自Benzinga Earnings专栏,原文如下:Anavex Life Sciences reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 26.32 percent. This is a 27.27 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Anavex生命科学公司2025年第一季度GAAP每股收益$(0.14)好于预期$(0.19),截至2024年12月31日公司现金及现金等价物为1.208亿美元,按当前现金使用率和范围预计可维持约4年","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL"],"gpt_icon":0},{"id":"2510132376","title":"Anavex Life Sciences(AVXL.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.14美元,前值为-0.11美元,预期值为-0.17美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510132376","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510132376?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:44","pubTimestamp":1739364291,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences(AVXL.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.14美元,前值为-0.11美元,预期值为-0.17美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12204448120548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AVXL"],"gpt_icon":0},{"id":"2510498333","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.03%报8.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510498333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510498333?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:09","pubTimestamp":1739286556,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时09分,Anavex Life Sciences Corp.股票出现波动,股价急速跳水5.03%。截至发稿,该股报8.37美元/股,成交量14.9578万股,换手率0.18%,振幅3.69%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为1.56%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112309179881c461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112309179881c461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2508468718","title":"Anavex Life Sciences Corp.盘中异动 早盘急速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508468718?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:07","pubTimestamp":1738681663,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时07分,Anavex Life Sciences Corp.股票出现异动,股价快速拉升5.09%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为1.01%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230743a2393058&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230743a2393058&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2508149313","title":"Anavex Life Sciences Corp.盘中异动 急速下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149313?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:31","pubTimestamp":1738593111,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分,Anavex Life Sciences Corp.股票出现波动,股价快速下挫5.18%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.29%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231519616fb57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231519616fb57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2508174999","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508174999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508174999?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:07","pubTimestamp":1738350422,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日03时07分,Anavex Life Sciences Corp.股票出现异动,股价大幅下挫5.12%。截至发稿,该股报9.08美元/股,成交量97.6056万股,换手率1.15%,振幅6.23%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.62%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103070296150aff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103070296150aff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2506308410","title":"Anavex Life Sciences Corp.盘中异动 早盘快速跳水5.19%报9.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506308410?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988332,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分,Anavex Life Sciences Corp.股票出现波动,股价急速下挫5.19%。截至发稿,该股报9.95美元/股,成交量6.024万股,换手率0.07%,振幅2.76%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.02%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722321296123961&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722321296123961&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2506521867","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506521867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506521867?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:46","pubTimestamp":1737733608,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时46分,Anavex Life Sciences Corp.股票出现异动,股价大幅拉升5.06%。截至发稿,该股报10.72美元/股,成交量24.1811万股,换手率0.29%,振幅6.72%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.39%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124234648abb7607e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124234648abb7607e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2505789517","title":"Anavex Life Sciences Corp.盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505789517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505789517?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:17","pubTimestamp":1737490642,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时17分,Anavex Life Sciences Corp.股票出现异动,股价急速上涨5.10%。截至发稿,该股报9.68美元/股,成交量114.208万股,换手率1.35%,振幅6.07%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为1.86%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041723abb38f83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041723abb38f83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2504816052","title":"Anavex Life Sciences Corp.盘中异动 急速跳水5.12%报9.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504816052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504816052?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:07","pubTimestamp":1737126423,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时07分,Anavex Life Sciences Corp.股票出现异动,股价快速跳水5.12%。截至发稿,该股报9.63美元/股,成交量42.6645万股,换手率0.50%,振幅5.57%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.66%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172307039607a13f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172307039607a13f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2503156539","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.10%报10.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503156539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503156539?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:53","pubTimestamp":1737039224,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时53分,Anavex Life Sciences Corp.股票出现异动,股价大幅下跌5.10%。截至发稿,该股报10.75美元/股,成交量18.9571万股,换手率0.22%,振幅5.83%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为0.76%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225344a22464bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225344a22464bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2503623275","title":"Anavex Life Sciences Corp.盘中异动 早盘急速上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503623275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503623275?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:47","pubTimestamp":1736952462,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时47分,Anavex Life Sciences Corp.股票出现波动,股价大幅上涨5.25%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体涨幅为0.95%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115224742a223028d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115224742a223028d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2503583961","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.08%报10.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503583961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503583961?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:37","pubTimestamp":1736779072,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时37分,Anavex Life Sciences Corp.股票出现波动,股价大幅下挫5.08%。截至发稿,该股报10.66美元/股,成交量17.3546万股,换手率0.20%,振幅3.29%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为1.02%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322375296025467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322375296025467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2502898797","title":"Anavex Life Sciences Corp.盘中异动 早盘大幅下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502898797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502898797?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:12","pubTimestamp":1736521920,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时12分,Anavex Life Sciences Corp.股票出现波动,股价大幅跳水5.07%。Anavex Life Sciences Corp.股票所在的生物技术行业中,整体跌幅为1.36%。Anavex Life Sciences Corp.公司简介:Anavex Life Sciences Corp 是一家临床阶段的生物制药公司,致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物,这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231200aba60d39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231200aba60d39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anavex.com","stockEarnings":[{"period":"1week","weight":0.2},{"period":"1month","weight":-0.0329},{"period":"3month","weight":-0.1951},{"period":"6month","weight":0.6567},{"period":"1year","weight":1.156},{"period":"ytd","weight":-0.1508}],"compareEarnings":[{"period":"1week","weight":0.0828},{"period":"1month","weight":-0.0448},{"period":"3month","weight":-0.0931},{"period":"6month","weight":-0.0768},{"period":"1year","weight":0.0657},{"period":"ytd","weight":-0.0827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anavex Life Sciences Corp.成立于2004年1月23日,位于内华达州。是一家临床阶段的生物制药公司,致力于开发差异化疗法,将精准医学应用于高度未满足需求的中枢神经系统(CNS)疾病。该公司目前有两个核心计划和两个种子计划。该公司的核心计划处于神经退行性疾病和神经发育疾病的临床和临床前开发的各个阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.045456},{"month":2,"riseRate":0.5,"avgChangeRate":0.134476},{"month":3,"riseRate":0.6,"avgChangeRate":0.076429},{"month":4,"riseRate":0.3,"avgChangeRate":-0.077092},{"month":5,"riseRate":0.777778,"avgChangeRate":0.060811},{"month":6,"riseRate":0.666667,"avgChangeRate":0.162785},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.058369},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.024515},{"month":9,"riseRate":0.555556,"avgChangeRate":0.020112},{"month":10,"riseRate":0.555556,"avgChangeRate":0.007649},{"month":11,"riseRate":0.4,"avgChangeRate":0.020111},{"month":12,"riseRate":0.5,"avgChangeRate":-0.021451}],"exchange":"NASDAQ","name":"Anavex Life Sciences Corp.","nameEN":"Anavex Life Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anavex Life Sciences Corp.,AVXL,Anavex Life Sciences Corp.股票,Anavex Life Sciences Corp.股票老虎,Anavex Life Sciences Corp.股票老虎国际,Anavex Life Sciences Corp.行情,Anavex Life Sciences Corp.股票行情,Anavex Life Sciences Corp.股价,Anavex Life Sciences Corp.股市,Anavex Life Sciences Corp.股票价格,Anavex Life Sciences Corp.股票交易,Anavex Life Sciences Corp.股票购买,Anavex Life Sciences Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}